ABSTRACT
Because the biodistribution of drugs-particularly novel therapeutic agents-is essentially unpredictable, uncontrollable and governed by poorly understood physiological processes, the idea of attaching such drugs to carriers, with more controllable biodistribution characteristics, has long been of interest (Duncan, 1992; Duncan et al., 1996; Matthews et al., 1996).
